From Our Partners
Monday, June 27, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DARPA Biochronicity Program Planning Grand Challenge

by Global Biodefense Staff
July 29, 2014

The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) is seeking innovative ideas to support the design of a potential Grand Challenge to leverage and advance DARPA investments in multidisciplinary predictive modeling of biological networks linked to cyclic/dynamic biological signatures and processes.

The program, termed Biochoronicity, seeks to build on research which suggests it may be possible to diagnose and predict the state of human health and disease, including distinction between different clinical phenotypes and prediction of disease evolution, based primarily on bio-markers present in peripheral blood.

DARPA BTO is interested in novel concepts to enable quantitative diagnoses and prediction of human health and disease, resiliency, clinical phenotypes and disease trajectories based upon easily measured time-sampled molecular data, which may include but is not limited to RNA, DNA, protein, and metabolic  profiles.

In order to foster new and innovative ideas, DARPA is considering developing a Grand Challenge that will require the use of dynamic mathematical models that integrate multiple types of data across time to enable health and disease predictions. In such a challenge, participants would be provided with a set of clinical molecular data (e.g. genomic, proteomic and other data), and associated metadata (e.g. age of patients, physiologic measures) and asked to quantitatively predict patients’ health status and susceptibility to disease, and/or possibly provide early diagnoses of chronic disease. New modeling techniques employing the latest advances in mathematics, biology and information sciences would be encouraged.

This RFI is specifically requesting information to help design the data collection, pre-analysis, and Challenge question formulation that would take place prior to announcing a potential Grand Challenge.

DARPA is seeking compelling proof-of-principle for quantitative prediction of any or all of the following conditions: infectious diseases, chronic diseases, autoimmune diseases and/or neurodegenerative pathologies. Data collection that leverages ongoing studies or trials resulting in lower costs is encouraged.

Total duration of the data collection phase including cohort management, data collection, pre-analyses of data and formulation of Challenge questions would be no longer than 12 months in duration.

Further details are available under Solicitation Number: DARPA-SN-14-48.  The response deadline is August 14, 2014.

From Our Partners
Tags: BiomarkersDARPARFI

Related Posts

Influenza Research
Biodetection

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022
NIH to Further Invest in Point-of-Care Technologies Research Network
Biodetection

NIH to Further Invest in Point-of-Care Technologies Research Network

May 10, 2022
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
Biodetection

Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools

May 6, 2022
Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories
Biosecurity

Supplemental Funding for Research at NIAID Regional Biocontainment Laboratories

May 5, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC